Total medical devices industry M&A deals worth $1.2bn were announced in North America in May 2021, led by Allergan Aesthetics’ $550m acquisition of Soliton, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 56.6% over the previous month of $2.72bn and a drop of 79.2% when compared with the last 12-month average of $5.67bn.
North America held a 37.34% share of the global medical devices industry M&A deal value that totalled $3.16bn in May 2021. With a 36.39% share and deals worth $1.15bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 21 deals during May 2021, marking a decrease of 12.50% over the previous month and a rise of 5.00% over the 12-month average. The US recorded 20 deals during the month.
North America medical devices industry M&A deals in May 2021: Top deals
The top five medical devices industry M&A deals accounted for 95.3% of the overall value during May 2021.
The combined value of the top five medical devices deals stood at $1.13bn, against the overall value of $1.2bn recorded for the month.
The top five medical devices industry M&A deals of May 2021 tracked by GlobalData were:
1) Allergan Aesthetics’ $550m acquisition of Soliton
2) The $260m acquisition of Nexcelom Bioscience by PerkinElmer
3) Roman Health Ventures’ $225m acquisition of Modern Fertility
4) The $60m acquisition of OBP Medical by CooperSurgical
5) Exact Sciences’ acquisition of 90% stake in PFS Genomics for $30.6m.
